Metraipolis › archive › dc_393d5d8fe80d

Improvement of recalcitrant Hailey-Hailey disease (ATP2C1-nonsyndromic epidermal differentiation disorder) with topical ruxolitinib 1.5% cream — Europe PMC PMID:42222696

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42222696
DOI
10.1093/skinhd/vzag002
License (as archived)
solo-consultazione
Archived
2026-11-04T10:43:29.035Z
SHA-256 of the archived text
08a559af4ca5be0ec9831cb3af5e95cac297c52a53f3919783ebf3baf5f9975c
Stable URL of this page
https://metraipolis.com/documento/dc_393d5d8fe80d

How to cite

Improvement of recalcitrant Hailey-Hailey disease (ATP2C1-nonsyndromic epidermal differentiation disorder) with topical ruxolitinib 1.5% cream — Europe PMC PMID:42222696 — Europe PMC (en), https://europepmc.org/article/MED/42222696 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_393d5d8fe80d (Metraipolis archive dc_393d5d8fe80d, sha256 08a559af4ca5be0ec9831cb3af5e95cac297c52a53f3919783ebf3baf5f9975c)
BibTeX
@misc{dc393d5d8fe80d,
  title = {Improvement of recalcitrant Hailey-Hailey disease (ATP2C1-nonsyndromic epidermal differentiation disorder) with topical ruxolitinib 1.5% cream — Europe PMC PMID:42222696},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42222696},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_393d5d8fe80d; sha256 08a559af4ca5be0ec9831cb3af5e95cac297c52a53f3919783ebf3baf5f9975c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42222696. Agents can read the archived copy with the MCP tool read_document.